Atossa Therapeutics
ATOS
ATOS
66 hedge funds and large institutions have $13M invested in Atossa Therapeutics in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 66 → 66 (0)
23% less capital invested
Capital invested by funds: $16.8M → $13M (-$3.84M)
Holders
66
Holding in Top 10
–
Calls
$166K
Puts
$61K
Top Buyers
| 1 | +$884K | |
| 2 | +$708K | |
| 3 | +$433K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$324K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$306K |
Top Sellers
| 1 | -$359K | |
| 2 | -$269K | |
| 3 | -$220K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$73.8K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$55.5K |
